- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07604337
Pre-emptive Local Anesthesia and Emergence Behavior After Pediatric Dental General Anesthesia (PEDLA-QOR)
Effects of Pre-emptive Local Anesthesia on Emergence Behavior and Early Recovery Quality After Ambulatory Pediatric Dental General Anesthesia: A Parallel-Group Randomized Controlled Trial
Descripción general del estudio
Estado
Intervención / Tratamiento
- Procedimiento: Pre-emptive local anesthesia will be administered by the pediatric dentist before the dental procedure according to the planned treatment area. The local anesthetic agent, total volume, total dose, do
- Procedimiento: Pre-emptive Local Anesthesia
- Droga: Articaine Hydrochloride With Epinephrine
Descripción detallada
This is a prospective, single-center, assessor-blinded, parallel-group randomized controlled trial in children aged 7-12 years undergoing ambulatory dental treatment under general anesthesia.
Participants will be randomized in a 1:1 ratio to one of two groups: pre-emptive local anesthesia or no local anesthesia. In the pre-emptive local anesthesia group, local anesthesia will be administered by the pediatric dentist before the dental procedure according to the planned treatment area. In the no local anesthesia group, local anesthesia will not be routinely administered. If clinically required, rescue analgesia or additional local anesthesia may be administered at the discretion of the responsible clinician and will be recorded.
Preoperative anxiety will be assessed using the modified Yale Preoperative Anxiety Scale. In the post-anesthesia care unit, sedation and arousal will be assessed using the Richmond Agitation-Sedation Scale before each behavioral and pain assessment. Emergence behavior will be evaluated using a PAED-derived 3-item emergence behavior assessment at 0, 5, 10, 15, and 30 minutes after arrival in the post-anesthesia care unit, only when the child meets predefined arousal criteria. Pain will be assessed using the Faces Pain Scale-Revised at the same time points. Recovery quality before discharge will be assessed using the QoR-15 Pictorial form.
The study aims to determine whether reducing peri-emergence nociceptive input with pre-emptive local anesthesia improves early emergence behavior, postoperative pain, and recovery quality in children undergoing ambulatory dental general anesthesia.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Seher Orbay Yaşlı, Assistant Professor of Anesthe
- Número de teléfono: +905052401933
- Correo electrónico: sehersin81@hotmail.com
Ubicaciones de estudio
-
-
Kayseri
-
Kayseri, Kayseri, Turquía (Türkiye), 38039
- Erciyes University Faculty of Dentistry
-
Contacto:
- SEHER Orbay Yaşlı
- Número de teléfono: 05052401933
- Correo electrónico: sehersin81@hotmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Children aged 7 to 12 years
- ASA physical status I or II
- Scheduled for ambulatory dental treatment under general anesthesia
- Ability to understand and respond to age-appropriate pain and recovery assessment tools
- Written informed consent obtained from a parent or legal guardian
- Child assent obtained when appropriate
Exclusion Criteria:
- Known allergy or contraindication to local anesthetic agents
- Developmental delay or cognitive impairment preventing assessment
- Autism spectrum disorder or severe behavioral disorder
- Neurological disease affecting behavior or consciousness
- Chronic analgesic or sedative medication use
- Severe hepatic, renal, cardiac, or respiratory disease
- Emergency dental procedure
- Need for postoperative hospital admission
- Inability to complete postoperative assessment tools
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Pre-emptive Local Anesthesia
Children randomized to this group will receive pre-emptive local anesthesia administered by the pediatric dentist before the dental procedure under general anesthesia.
|
Pre-emptive local anesthesia will be administered by the pediatric dentist before the dental procedure according to the planned treatment area.
The local anesthetic agent, total volume, total dose, dose per kilogram, and injection sites will be recorded.
Pre-emptive local anesthesia will be administered by the pediatric dentist before the dental procedure according to the planned treatment area.
The local anesthetic agent, total volume, total dose, dose per kilogram, and injection sites will be recorded.
Articaine hydrochloride with epinephrine will be administered as local anesthesia by the pediatric dentist before the dental procedure in participants randomized to the pre-emptive local anesthesia group.
The total volume, total dose, dose per kilogram, and injection sites will be recorded.
|
|
Sin intervención: No Local Anesthesia
Children randomized to this group will undergo dental treatment under general anesthesia without routine pre-emptive local anesthesia.
Rescue analgesia or additional local anesthesia may be administered if clinically required and will be recorded.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Emergence Behavior Score During the First 30 Minutes in the Post-Anesthesia Care Unit
Periodo de tiempo: PACU minutes 0, 5, 10, 15, and 30
|
Emergence behavior will be assessed using a PAED-derived 3-item emergence behavior assessment including eye contact, purposeful behavior, and awareness of surroundings.
Each item is scored from 0 to 4, with a total score ranging from 0 to 12. Higher scores indicate greater emergence behavior disturbance.
Assessments will be performed only when the Richmond Agitation-Sedation Scale score is ≥ -1.
|
PACU minutes 0, 5, 10, 15, and 30
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Postoperative Pain Score
Periodo de tiempo: PACU minutes 0, 5, 10, 15, and 30
|
Pain will be assessed using the Faces Pain Scale-Revised.
Scores range from 0 to 10, with higher scores indicating greater pain intensity.
|
PACU minutes 0, 5, 10, 15, and 30
|
|
Recovery Quality Before Discharge
Periodo de tiempo: Before discharge on day of surgery
|
Recovery quality will be assessed using the QoR-15 Pictorial form before discharge.
The total score ranges from 0 to 150, with higher scores indicating better postoperative recovery quality.
|
Before discharge on day of surgery
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Manifestaciones neurológicas
- Enfermedades del Sistema Nervioso
- Desordenes mentales
- Complicaciones Postoperatorias
- Procesos Patológicos
- Confusión
- Manifestaciones neuroconductuales
- Trastornos neurocognitivos
- Delirio
- Condiciones Patológicas, Signos y Síntomas
- Signos y síntomas
- Delirio de emergencia
- Compuestos de azufre
- Químicos orgánicos
- Compuestos heterocíclicos, 1 anillo
- Compuestos heterocíclicos
- Hidrocarburos
- Hidrocarburos, cíclico
- Hidrocarburos, aromáticos
- Amina
- Catecols
- Fenoles
- Derivados de benceno
- Alcoholes
- Amino alcoholes
- Etanolaminas
- Tiofenos
- Monoaminas biogénicas
- Aminas biogénicas
- Catecolaminas
- Epinefrina
- Carticaína
Otros números de identificación del estudio
- PEDGA-LA-2026
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Delirio de emergencia
-
Jubilee Mission Medical College and Research InstituteINCRE fellowship from DBT, govt of IndiaTerminadoSíntomas de abstinencia de alcohol | Delirium Tremens (DT)
-
Denver Health and Hospital AuthorityTerminadoDelirio por abstinencia de alcohol | Hiperactividad autonómica asociada a la abstinencia de alcohol | Alucinosis por abstinencia de alcohol | Delirium Tremens inducido por abstinencia de alcoholEstados Unidos